SCHEMBL6851491

SCHEMBL6851491

CCCCCCCCC=CCC=CCCCCC(=O)OC

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 2/20 0.69
OXER1 Q8TDS5 2/20 0.69
EPHX2 P34913 1/20 0.68
ALDH1A1 P00352 4/20 0.67
F7 P08709 4/20 0.67
F3 P13726 4/20 0.67
KDM4E B2RXH2 3/20 0.67
PPARG P37231 3/20 0.67
PPARD Q03181 3/20 0.67
PPARA Q07869 3/20 0.67
FABP3 P05413 3/20 0.67
FFAR1 O14842 3/20 0.67
PTGS1 P23219 2/20 0.67
DUSP3 P51452 1/20 0.67
PTPN7 P35236 1/20 0.67
LMNA P02545 1/20 0.67
CYP3A4 P08684 1/20 0.67
CYP19A1 P11511 1/20 0.67
FABP4 P15090 1/20 0.67
HPGD P15428 1/20 0.67

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16322672 1.00 ALOX5 (0.69) ALOX5OXER1EPHX2ALDH1A1F7
SCHEMBL6851489 1.00 ALOX5 (0.69) ALOX5OXER1EPHX2ALDH1A1F7
SCHEMBL5090838 1.00 ALOX5 (0.69) ALOX5OXER1EPHX2ALDH1A1F7
SCHEMBL2187914 1.00 ALOX5 (0.69) ALOX5OXER1EPHX2ALDH1A1F7
SCHEMBL814776 1.00 ALOX5 (0.69) ALOX5OXER1EPHX2ALDH1A1F7
SCHEMBL13140452 1.00 ALOX5 (0.69) ALOX5OXER1EPHX2ALDH1A1F7
SCHEMBL6849890 1.00 ALOX5 (0.69) ALOX5OXER1EPHX2ALDH1A1F7
SCHEMBL814775 1.00 ALOX5 (0.69) ALOX5OXER1EPHX2ALDH1A1F7
SCHEMBL813264 1.00 ALOX5 (0.69) ALOX5OXER1EPHX2ALDH1A1F7
SCHEMBL12479211 1.00 ALOX5 (0.69) ALOX5OXER1EPHX2ALDH1A1F7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021050786-A1 CANNABIN OID COMPOSITIONS WITH IMPROVED ORGANOLEPTIC AND THERAPEUTIC PROPERTIES, METHOD OF PRODUCTION, AND USE THEREOF CALIFORNIA AMBER INC. (US) 2021-03-18 WO claimed
US-20210068444-A1 CANNABINOID COMPOSITIONS WITH IMPROVED ORGANOLEPTIC AND THERAPEUTIC PROPERTIES, METHOD OF PRODUCTION, AND USE THEREOF CALIFORNIA AMBER INC. 2021-03-11 US claimed
US-20240084343-A1 METHODS OF USING NATURAL AND ENGINEERED ORGANISMS TO PRODUCE SMALL MOLECULES FOR INDUSTRIAL APPLICATION KIVERDI INC (US) 2024-03-14 US disclosed
WO-2024014801-A1 METHOD FOR PREPARING SAPIENIC ACID, TRANS-ISOMER THEREOF, AND SAPIENIC ACID ESTER 전종열 2024-01-18 WO disclosed
CN-114894917-A Detection and fingerprint spectrum construction method for volatile components of nardostachys chinensis bunge 山东步长制药股份有限公司 2022-08-12 CN disclosed
CN-111991540-A Traditional Chinese medicine composition for treating hepatic fibrosis and preparation method and application thereof 浙江省中医药研究院 2020-11-27 CN disclosed
US-6812020-B1 BY CULTURING IN A MEDIUM A MUTANT (MORTIERELLA) STRAIN THAT PRODUCES ARACHIDONIC ACID; DELTA 12 DESATURATION IS DECREASED BUT DELTA 5/6 DESATURATION/CHAIN LENGTH ELONGATION IS ELEVATED SUNTORY LIMITED (JP) 2004-11-02 US disclosed
EP-0825263-B1 Process for producing omega-9 highly unsaturated fatty acid and lipid containing the same SUNTORY LTD (JP) 2004-04-07 EP disclosed
US-6150144-A PREPARING FATTY ACID COMPOUND; CULTURING MUTANT MICROORGANISM WHICH PRODUCES ARACHIDONIC ACID AND IN WHICH DESATURASE ACTVITY IS REDUCED AND CHAIN ELONGATION HAS BEEN AMPLIFIED, RECOVER FATTY ACID COMPOUND SUNTORY LIMITED (JP) 2000-11-21 US disclosed
EP-0825263-A2 Process for producing omega-9 highly unsaturated fatty acid and lipid containing the same SUNTORY LIMITED (JP) 1998-02-25 EP disclosed
EP-0535939-B1 Process for production of omega 9 type polyunsaturated fatty acid SUNTORY LTD (JP) 1997-07-09 EP disclosed
US-5322780-A Culturing Mortierella microorganism SUNTORY LIMITED (JP) 1994-06-21 US disclosed